| Receptor type | Subtypes | Ligand(s)/interacted factors |
| | CCR1 | CCL3 (MIP-1α), CCL5 (RANTES), CCL7 (MCP-3), CCL9 (MIP-1γ), CCL14 (HCC-1), CCL15 (HCC-2/leukotactin-1), CCL16 (HCC-4/LEC), CCL23 (MPIF-1) | Chemokine receptor | CCR2 | CCL2 (MCP-1), CCL7 (MCP-3), CCL8 (MCP-2), CCL13 (MCP-4), CCL16 (HCC-4/LEC) | | CCR5 | CCL3 (MIP-1α), CCL4 (MIP-1β), CCL5 (RANTES) | | CXCR3 | CXCL9 (Mig), CXCL10 (IP-10), CXCL11 (I-TAC) | | CX3CR1 | CX3CL1 (Fractalkine) |
| Purinergic receptor | P2X4, P2Y7, P2Y12 P2Y6 | ATP, ADP UDP |
| TLR | TLR1 TLR2 TLR4 TLR6 TLR9 | Triacyl lipopeptides Glycolipids, Hsp70, HMGB1, Aβ LPS, Hsp Diacyl lipopeptides CpG-DNA |
| Phosphatidylserine (PS) receptor | MFG-E8, Tim1, Tim4 RAGE | PS of apoptotic cells Aβ, AGE, HMGB1 PS of apoptotic cells |
| Scavenger receptor (SR) | SR-AI/II (CD204), SR-BI, CD36 | Cellular debris, apoptotic cells, Aβ (CD36) |
| Immunoglobulin (Ig) receptor | FcγRI, FcγRIII | Ig-opsonized particles |
| Complement receptor (CR) | CR3 (MAC-1; CD11b/CD18) | Complement components, opsonized particles |
| Other phagocytosis-related receptor | CD14 CD47 CD200R TREM2 | LPS, Aβ SIRPα (CD172a) CD200 Hsp60, DAP12 |
|
|